Hybio Pharmaceutical Co., Ltd

Hybio, founded in 1998, with registered capital ove four hundred million RMB, the headquarters located in Shenzhen High-Tech Park, owns the top labs for synthesis, purification, lyophilization, quality research, formulation study and pilot production of polypeptide drugs, special instruments and equipment from US, Germany and Switzerland etc. Specializes in R&D and manufacturing of diverse and large quantities of peptide products, Hybio is a GMP-approved pharmaceutical company with most advanced facilities and most professional technical team for 23 years, the first entered into peptide pharmaceutical industry in China and listed in market, the only enterprise that has developed a full range of peptide products and services, including peptide APIs, peptide CRO&CMO services and peptide finished dosage products. Supplying customers worldwide, Hybio is a company with decades of experience in receiving and passing audits & inspections not only from authorities and clients locally but also internationally!